Position in AMGN
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$292,592
+$9,001 QoQ
Shares Held
808
+0.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#2,573
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TRUE Private Wealth Advisors holds $27,309,850 across 8 Drug Manufacturers - General names. AMGN ranks #7 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
6,739 | $8,082,959 | |
| 2 | JNJ |
Johnson & Johnson
|
26,804 | $6,807,411 | |
| 3 | ABBV |
AbbVie Inc.
|
24,787 | $6,237,400 | |
| 4 | MRK |
Merck & Co., Inc.
|
27,029 | $3,473,226 | |
| 5 | PFE |
Pfizer Inc
|
66,968 | $1,612,589 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
9,727 | $560,469 | |
| 7 | AMGN |
Amgen Inc
This page
|
808 | $292,592 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,925 | $243,204 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $292,592 | 808 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $283,591 | 806 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $256,611 | 784 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $221,244 | 784 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $218,900 | 784 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $246,436 | 791 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $204,602 | 785 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $270,978 | 841 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $868,298 | 2,779 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $775,340 | 2,727 | Shares | Sole | 2024-04-25 | |
| 2023-12-31 | $739,347 | 2,567 | Shares | Sole | 2024-01-30 | |
| 2023-09-30 | $498,012 | 1,853 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $350,791 | 1,580 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $336,274 | 1,391 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $369,797 | 1,408 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $299,331 | 1,328 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $289,283 | 1,189 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $286,314 | 1,184 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $371,875 | 1,653 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $383,620 | 1,804 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $441,431 | 1,811 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $546,137 | 2,195 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $402,130 | 1,749 | Shares | Sole | 2021-01-11 | |
| 2020-09-30 | $436,901 | 1,719 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $290,343 | 1,231 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $221,583 | 1,093 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||